Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-03-22
2005-03-22
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S365000, C514S367000, C514S374000, C514S385000, C514S415000, C514S443000, C514S464000, C544S239000, C549S049000, C549S070000, C549S462000, C549S483000, C548S452000, C564S218000, C564S308000
Reexamination Certificate
active
06869953
ABSTRACT:
New compounds represented by the formulaor pharmaceutically acceptable salts or prodrugs thereof,whereinX1and X2are each independently selected from a CH group or a nitrogen atom; andR is an optionally substituted five or six membered nonaromatic carbocyclic ring or a nonaromatic or aromatic heterocyclic ring, whereby the ring is optionally condensed with a 6-membered, optionally substituted carbocyclic aromatic ring.
REFERENCES:
patent: 4001416 (1977-01-01), Pommer et al.
patent: 2 062 265 (1992-05-01), None
patent: 242 851 (1987-10-01), None
patent: 847 992 (1998-06-01), None
patent: 2 150 961 (1973-04-01), None
patent: 2 167 954 (1973-08-01), None
patent: 2 193 548 (1974-02-01), None
patent: 2 165 537 (1980-04-01), None
patent: 1153904 (1999-06-01), None
patent: WO 0138322 (2001-05-01), None
patent: WO 01 68604 (2001-09-01), None
patent: WO 01 72705 (2001-10-01), None
Mahlknecht et al. Mol. Med. 6(8): 623-44, 2000.*
Simone In Cecil Text Book of Medicine, 20thEdition, pp. 1004-1010.*
De Selma, R. C., J. Org. Chem., 27, 2163-2165, 1962.*
Rastogi et al., Indian J. Chem., Sect. B, 21B (5), pp. 485-487 (1982).
Moll et al., Z. Chem. 4, 17, pp. 133-134 (1977); also Chem. Abstracts, 87:84749h (1977).
Hassan et al., Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 39B(10), pp. 764-768 (2000).
Banihashemi et al., J. Appl. Polyn. Sci., 35, pp. 51-57 (1979).
Vyas et al., J. Indian Chem. Soc., 68(5), pp. 294-295 (1991).
Kabanos et al., J. Chem. Soc. Dalton Trans., pp. 2729-2733 (1992).
Adembri et al., J.Chem. Soc. Perkin I, 9, pp. 1022-1026 (1974).
Chimichi et al., J.Chem. Soc. Perkin II, 2, 9, pp. 1339-1343 (1980).
Prewysz-Kwinto, Chem Abstract XP002188608 & Khim. Geterotsikl. Soedin, (6), pp. 756-759 (1987).
Hatchard W.R., Chem Abstract XP002228920, J. Org. Chem., vol. 29, pp. 665-668 (1964).
Zarin, P.P., et al., Chem Abstract XP002228921, Chem. Heterocycl. Compd., vol. 10, pp. 96-98 (1974).
Gortinskaja, et al., Chem Abstract XP002228922, Zh. Obshch. Khim., vol. 25, pp. 2313-2315 (1955).
Balaban, King, Chem Abstract XP002228923, J. Chem. Soc., vol. 127, p. 2710 (1925).
Hu 155 098 A, Chem Abstract XP002228924, Chinoin Gyogyszer Es Vegyeszeti Termekek Gyora Rt, (1966).
Holan G., et al, Chem Abstract XP002228925, J. Chem. Soc. C., pp. 20-25 (1967).
De Selms R.C., Chem Abstract XP002228926, J. Org. Chem., vol. 27, pp. 2163-2165 (1962).
Prewysz-Kwinto A., Chem Abstract XP002228927, Chem Heterocycl. Compd., vol. 23, No. 6, pp. 624-627 ( 1987).
Bedair A.H., Chem Abstract XP002228928, J. Prakt. Chem., vol. 329, No. 2, pp. 359-364 (1987).
Hudkins R.L., Chem Abstract XP002228929, Heterocycles, vol. 41, No. 5, pp. 1045-1050 (1995).
Zalesov V.V., et al., Chem Abstract XP002228930, Russ. J. Org. Chem., vol. 31, No. 8, pp. 1104-1108 (1995).
Burgart YA. V., et al., Chem Abstract XP002228931, Russ. J. Org. Chem., vol. 34, No. 3, pp. 375-380 (1998).
Salakhov M.S., et al., Chem Abstract XP002228932, Russ J. Org. Chem., vol. 35, No. 35, pp. 397-401 (1999).
Blood, Chem Abstract XP002228933, 42nd Annual Meeting of the American Society of Hematology; San Francisco, CA, vol. 96, No. 11 Part 2 (2000).
Nicolaus, B J R, Chem Abstract XP002197412, Decision Making in Drug Research, XX, XX, pp 173-186 (1983).
Haag Rainer
Leser-Reiff Ulrike
Limberg Anja
Weidner Michael
Zimmermann Gerd
Balasubramanian Venkataraman
Hoffman-La Roche Inc.
Johnston George W.
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
N-monoacylated derivatives of o-phenylenediamines, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-monoacylated derivatives of o-phenylenediamines, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-monoacylated derivatives of o-phenylenediamines, their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3442688